NEO NeoGenomics, Inc. - Common Stock
About NeoGenomics, Inc. - Common Stock Company overview from Wikipedia
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Read more
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.
## History
NeoGenomics first received state and national-level laboratory certifications in 2002. Three years later in 2005, the company developed a technical-only service model using FISH.
In 2013, the company launched its sequencing platform and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.
In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc., a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare. Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.
In November 2017, NeoGenomics established their first headquarters outside the United States in Rolle, Switzerland.
In September 2024, the District Court for the Middle District of North Carolina entered a permanent injunction against NeoGenomics’ accused RaDaR assay, which was preliminarily enjoined in December 2023.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
NEO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
NEO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
NEO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 4 25.0%
- Buy 7 43.8%
- Hold 5 31.2%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
9 analysts · 2026-08-14Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $0.05 | $0.03 | 0.02% |
| March 31, 2026 | $0.01 | $0.01 | 0.00% |
| Dec. 31, 2025 | $0.06 | $0.04 | 0.02% |
| Sept. 30, 2025 | $0.03 | $0.02 | 0.01% |
| June 30, 2025 | $0.03 | $0.02 | 0.01% |
| March 31, 2025 | $0.00 | $-0.01 | 0.01% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| GRDN | — | — | 17.9% | 3.4% | 24.8% | 20.2% |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | — |
| ADUS | — | 20.6 | 23.2% | — | — | — |
| WGS | — | — | — | — | — | — |
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | — |
| AGL | $7.14B | — | -2.1% | -6.6% | -146.1% | — |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
| INNV | $500M | -16.8 | 11.8% | -3.5% | -12.0% | 18.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 18
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Cost of Revenue | $413M | $370M | $347M | $322M | $297M | $259M | $212M | $149M | $138M | $134M | $56M | $46M | |
| Gross Profit | $314M | $290M | $245M | $188M | $187M | $186M | $197M | $127M | $102M | $98M | $44M | $41M | |
| R&D Expense | $37M | $31M | $27M | $30M | $22M | $8M | $8M | $3M | $4M | $5M | $4M | $3M | |
| SG&A Expense | $273M | $260M | $243M | $243M | $221M | $144M | $128M | $85M | $70M | $64M | $34M | $24M | |
| Operating Expenses | $430M | $382M | $352M | $346M | $306M | $200M | $184M | $117M | $99M | $96M | $49M | $38M | |
| Operating Income | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | $10M | $3M | $2M | $-6M | $2M | |
| Interest Expense | · | · | $7M | $8M | $8M | $7M | $4M | $6M | $6M | · | $854.0K | $985.0K | |
| Interest Income | $9M | $18M | $17M | $6M | $3M | · | · | · | · | · | · | · | |
| Other Non-op | $296.0K | $-379.0K | $644.0K | $-213.0K | $-499.0K | $8M | $-5M | $14.0K | $-12.0K | $0 | $2M | $56.0K | |
| Pretax Income | $-110M | $-81M | $-97M | $-159M | $-15M | $-14M | $4M | $4M | $-3M | $-8M | $-4M | $1M | |
| Income Tax | $-2M | $-2M | $-9M | $-15M | $-7M | $-18M | $-4M | $1M | $-2M | $-2M | $-2M | $157.0K | |
| Net Income | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| Shares (Basic) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 108,579,000 | 100,470,000 | 85,618,000 | 79,426,000 | 77,542,000 | 60,526,000 | 53,483,000 | |
| Shares (Diluted) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 111,794,000 | 103,615,000 | 91,568,000 | 79,426,000 | 77,542,000 | 60,526,000 | 56,016,000 | |
| EBITDA | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | · | $2M | · | $-6M | · |
Balance Sheet 29
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $367M | $342M | $263M | $317M | $229M | $173M | $10M | $13M | $13M | $23M | $34M | |
| Receivables | $159M | $151M | $131M | $120M | $112M | $107M | $94M | $77M | $60M | $56M | $49M | $20M | |
| Inventory | $29M | $27M | $24M | $24M | $23M | $30M | $14M | $9M | $7M | $6M | $5M | $3M | |
| Prepaid Expense | $21M | $20M | $18M | $15M | $12M | $12M | $6M | $8M | $5M | $5M | $5M | $1M | |
| Other Current Assets | $7M | $12M | $8M | $8M | $8M | $5M | $3M | $561.0K | $1M | · | · | · | |
| Current Assets | $376M | $596M | $597M | $605M | $682M | $449M | $291M | $104M | $86M | $79M | $82M | $59M | |
| PP&E (Net) | $85M | $94M | $92M | $102M | $109M | $86M | $64M | $61M | $37M | $34M | $35M | $15M | |
| PP&E (Gross) | $294M | $284M | $250M | $234M | $219M | $179M | $133M | $111M | $77M | $61M | $61M | $35M | |
| Accum. Depreciation | $209M | $190M | $158M | $132M | $110M | $93M | $69M | $50M | $41M | $27M | $27M | $20M | |
| Goodwill | $524M | $523M | $523M | $523M | $527M | $211M | $199M | $198M | $147M | $147M | $147M | $3M | |
| Intangibles | $287M | $340M | $373M | $408M | $442M | $121M | $127M | $140M | $74M | $77M | $88M | $4M | |
| Other Non-current Assets | $9M | $6M | $5M | $5M | $7M | $5M | $3M | $3M | $891.0K | $174.0K | $129.0K | $141.0K | |
| Total Assets | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Accounts Payable | $23M | $22M | $20M | $21M | $18M | $25M | $20M | $18M | $10M | $17M | $12M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $88M | $301M | $96M | $90M | $87M | $73M | $64M | $61M | $36M | $38M | $40M | $15M | |
| Capital Leases | $63M | $61M | $68M | $69M | $72M | $42M | $24M | $5M | $5M | $5M | $5M | $5M | |
| Deferred Tax | $18M | $22M | $24M | $35M | $55M | $5M | $16M | $22M | $7M | · | $16M | $821.0K | |
| Other Non-current Liabilities | $12M | $12M | $13M | $13M | $14M | $4M | $4M | $3M | $283.0K | · | · | · | |
| Total Liabilities | $523M | $736M | $740M | $742M | $762M | $294M | $202M | $185M | $140M | $151M | $113M | $21M | |
| Long-term Debt | $342M | $541M | $538M | · | · | · | · | $102M | $97M | $98M | $55M | · | |
| Total Debt | $342M | $541M | · | · | · | $0 | · | · | $95M | · | $53M | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | $60.0K | |
| Retained Earnings | $-434M | $-326M | $-247M | $-159M | $-15M | $-7M | $-11M | $-19M | $-58M | $-52M | $-22M | $-19M | |
| Treasury Stock | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $-206.0K | $-2M | $-4M | $-638.0K | $10.0K | $-2M | $-579.0K | $274.0K | · | · | · | |
| Stockholders' Equity | $837M | $902M | $942M | $998M | $1.11B | $694M | $507M | $320M | $172M | $162M | $209M | $60M | |
| Liabilities + Equity | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Shares Outstanding | 128,989,152 | 128,145,333 | 127,369,142 | 126,913,992 | 124,107,500 | 112,075,474 | 104,781,236 | 94,465,440 | 80,462,574 | 78,571,158 | 75,820,307 | 60,242,818 |
Cash Flow 15
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $26M | $20M | $16M | $16M | $16M | $7M | $5M | |
| Stock-based Comp | $41M | $33M | $25M | $25M | $22M | $10M | $10M | $7M | $6M | $5M | $3M | $641.0K | |
| Deferred Tax | $-3M | $-3M | $-10M | $-15M | $-7M | $-18M | $-4M | $2M | $-2M | $-2M | $-2M | · | |
| Amort. of Intangibles | $32M | $33M | $35M | $34M | $23M | $10M | $10M | $6M | $7M | $7M | $412.0K | $295.0K | |
| Restructuring | $0 | $7M | $11M | $5M | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $5M | $7M | $-2M | $-66M | $-27M | $1M | $23M | $45M | $18M | $21M | $6M | $9M | |
| CapEx | $27M | $41M | $29M | $31M | $64M | $29M | $20M | $14M | $14M | $8M | $2M | $4M | |
| Investing Cash Flow | $-12M | $13M | $77M | $517.0K | $-632M | $-159M | $-20M | $-140M | $-14M | · | · | · | |
| Stock Issued | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | $9M | $3M | · | · | $34M | |
| Net Stock Activity | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-200M | $5M | $5M | $12M | $725M | $236M | $159M | $92M | $-4M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | $78M | $163M | $-3M | $296.0K | $-11M | $-10M | $29M | |
| Taxes Paid | $515.0K | $207.0K | $175.0K | $180.0K | $148.0K | $246.0K | $319.0K | $-31.0K | $284.0K | $290.0K | · | · | |
| Free Cash Flow | $-22M | $-34M | $-31M | $-97M | $-91M | $-28M | $3M | · | $4M | · | $4M | · | |
| Levered FCF | · | · | $-37M | $-98M | $-94M | $-26M | $-5M | · | · | · | $4M | · |
Profitability 8
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% | 41.8% | 48.1% | · | · | · | 875.1% | · | |
| Operating Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| Net Margin | -14.8% | -11.9% | -14.9% | -28.3% | -1.7% | 0.94% | 2.0% | · | · | · | -50.7% | · | |
| Pretax Margin | -15.2% | -12.2% | -16.4% | -31.3% | -3.1% | -3.2% | 0.89% | · | · | · | -89.8% | · | |
| EBITDA Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| ROA | -7.2% | -4.7% | -5.1% | -8.0% | -0.58% | 0.49% | 1.3% | · | -0.25% | · | -1.1% | · | |
| ROE | -12.8% | -8.7% | -9.3% | -14.3% | -0.74% | 0.61% | 1.6% | · | -0.50% | · | -1.9% | · | |
| ROIC | -9.6% | -6.2% | -10.4% | -14.3% | -5.9% | 0.60% | 5.6% | · | 0.21% | · | -1.2% | · |
Liquidity & Solvency 5
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 | 6.1 | 4.5 | · | 2.4 | · | 2.5 | · | |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 | 4.6 | 4.2 | · | 2.1 | · | 1.8 | · | |
| Debt / Equity | 0.4 | 0.6 | · | · | · | 0.0 | · | · | 0.5 | · | 0.3 | · | |
| LT Debt / Equity | 0.4 | 0.4 | · | · | · | · | · | · | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -15.6 | -104.7 | -23.4 | -2.0 | 3.5 | · | · | · | -6.6 | · |
Efficiency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | 0.5 | 0.7 | · | · | · | 0.0 | · | |
| Inventory Turnover | 14.9 | 14.6 | 14.3 | 13.5 | 11.2 | 11.8 | 18.4 | · | 20.1 | · | 14.5 | · | |
| Receivables Turnover | 4.7 | 4.7 | 4.7 | 4.4 | 4.4 | 4.4 | 4.8 | · | · | · | 0.1 | · |
Growth Rates 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 11.7% | 16.1% | 5.2% | 9.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.6% | 10.9% | 10.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Net Income TTM | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| Market Cap | $1.51B | $2.10B | $2.05B | $1.15B | $3.82B | $5.64B | $2.76B | · | $713M | · | $597M | · | |
| Enterprise Value | $1.69B | $2.27B | · | · | · | $5.41B | · | · | $795M | · | $626M | · | |
| P/E | -49.0 | -68.7 | -67.4 | -38.5 | -142.2 | -224.3 | -121.9 | -52.5 | -36.9 | -35.7 | -196.8 | 208.5 | |
| P/S | 2.1 | 3.2 | 3.5 | 2.2 | 7.9 | 12.7 | 6.8 | · | 3.0 | · | 119.3 | · | |
| P/B | 1.8 | 2.3 | 2.2 | 1.1 | 3.5 | 8.1 | 5.4 | · | 4.1 | · | 2.8 | · | |
| P / Tangible Book | 58.7 | 52.6 | 45.0 | 17.1 | 27.5 | 15.6 | · | · | · | · | · | · | |
| P / Cash Flow | 288.1 | 298.9 | -1051.4 | -17.4 | -143.1 | 3864.0 | 118.2 | · | 39.5 | · | 93.3 | · | |
| P / FCF | -69.2 | -61.7 | -66.9 | -11.8 | -42.1 | -204.1 | 827.3 | · | 164.0 | · | 142.8 | · | |
| EV / EBITDA | -14.6 | -24.7 | · | · | · | -386.8 | · | · | 342.1 | · | -111.1 | · | |
| EV / FCF | -77.6 | -66.8 | · | · | · | -195.9 | · | · | 182.9 | · | 149.9 | · | |
| EV / Revenue | 2.3 | 3.4 | · | · | · | 12.2 | · | · | 3.3 | · | 125.2 | · | |
| Earnings Yield | -2.0% | -1.5% | -1.5% | -2.6% | -0.70% | -0.45% | -0.82% | -1.9% | -2.7% | -2.8% | -0.51% | 0.48% |
Income Statement 16
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $202M | $187M | $190M | $188M | $181M | $168M | $172M | $168M | $165M | $156M | $156M | $152M | $147M | $137M | $139M | $129M | |
| Cost of Revenue | $110M | $106M | $107M | $107M | $104M | $95M | $95M | $93M | $92M | $91M | $88M | $90M | $87M | $82M | $82M | $80M | |
| Gross Profit | $92M | $81M | $83M | $80M | $77M | $73M | $77M | $75M | $72M | $65M | $68M | $62M | $60M | $55M | $57M | $49M | |
| R&D Expense | $11M | $10M | $9M | $9M | $9M | $10M | $8M | $8M | $8M | $8M | $7M | $5M | $8M | $7M | $7M | $7M | |
| SG&A Expense | $64M | $66M | $64M | $70M | $72M | $68M | $64M | $67M | $63M | $66M | $60M | $61M | $60M | $62M | $55M | $64M | |
| Operating Expenses | $102M | $99M | $97M | $107M | $125M | $101M | $96M | $96M | $94M | $96M | $86M | $87M | $90M | $90M | $83M | $88M | |
| Operating Income | $-10M | $-18M | $-13M | $-27M | $-48M | $-28M | $-18M | $-21M | $-22M | $-31M | $-19M | $-24M | $-30M | $-35M | $-26M | $-40M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $-3M | $-3M | $2M | · | $139.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | · | · | |
| Other Non-op | $-17.0K | $-12.0K | $84.0K | $-335.0K | $482.0K | $65.0K | $-431.0K | $317.0K | $-2.0K | $-263.0K | $124.0K | $-96.0K | $730.0K | $-114.0K | $-1.0K | $25.0K | |
| Pretax Income | $2M | $-18M | $-12M | $-26M | $-46M | $-26M | $-16M | $-18M | $-19M | $-28M | $-15M | $-21M | $-27M | $-34M | $-26M | $-40M | |
| Income Tax | $-412.0K | $-472.0K | $-3M | $740.0K | $-724.0K | $266.0K | $-804.0K | $-150.0K | $-375.0K | $-620.0K | $-960.0K | $-3M | $-2M | $-3M | $-3M | $-3M | |
| Net Income | $2M | $-17M | $-10M | $-27M | $-45M | $-26M | $-15M | $-18M | $-19M | $-27M | $-14M | $-19M | $-24M | $-31M | $-23M | $-37M | |
| Shares (Basic) | 129,628,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| Shares (Diluted) | 130,831,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| EBITDA | $-10M | $-18M | · | $-27M | $-48M | $-28M | · | $-21M | $-22M | $-31M | · | $-24M | $-30M | $-35M | · | $-40M |
Balance Sheet 27
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $146M | $146M | $160M | $164M | $155M | $346M | $367M | $362M | $355M | $332M | · | $306M | $289M | $276M | · | $266M | |
| Receivables | $175M | $167M | $159M | $155M | $153M | $151M | $151M | $151M | $147M | $140M | · | $133M | $125M | $119M | · | $112M | |
| Inventory | $27M | $30M | $29M | $28M | $34M | $30M | $27M | $24M | $23M | $20M | · | $24M | $25M | $24M | · | $24M | |
| Prepaid Expense | $24M | $24M | $21M | $22M | $23M | $23M | $20M | $18M | $17M | $19M | · | $19M | $17M | $16M | · | $17M | |
| Other Current Assets | $10M | $7M | $7M | $11M | $10M | $12M | $12M | $8M | $9M | $9M | · | $9M | $8M | $8M | · | $8M | |
| Current Assets | $381M | $374M | $376M | $382M | $393M | $574M | $596M | $590M | $584M | $574M | · | $587M | $585M | $585M | · | $603M | |
| PP&E (Net) | $81M | $84M | $85M | $85M | $85M | $90M | $94M | $93M | $92M | $88M | · | $95M | $100M | $103M | · | $107M | |
| PP&E (Gross) | · | · | $294M | · | · | · | $284M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $223M | $216M | $209M | $209M | $201M | $199M | $190M | $181M | $176M | $168M | · | $155M | $147M | $139M | · | $125M | |
| Goodwill | $524M | $524M | $524M | $524M | $524M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | · | $523M | |
| Intangibles | $271M | $279M | $287M | $294M | $302M | $331M | $340M | $348M | $356M | $365M | · | $382M | $391M | $399M | · | $417M | |
| Other Non-current Assets | $9M | $10M | $9M | $8M | $7M | $6M | $6M | $6M | $4M | $4M | · | $5M | $5M | $5M | · | $7M | |
| Total Assets | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Accounts Payable | $21M | $26M | $23M | $23M | $27M | $16M | $22M | $17M | $17M | $18M | · | $17M | $18M | $23M | · | $14M | |
| Current Liabilities | $106M | $85M | $88M | $98M | $100M | $280M | $301M | $296M | $290M | $77M | · | $93M | $95M | $87M | · | $85M | |
| Capital Leases | $65M | $61M | $63M | $64M | $67M | $60M | $61M | $62M | $63M | $65M | · | $62M | $65M | $67M | · | $70M | |
| Deferred Tax | $17M | $17M | $18M | $21M | $20M | $21M | $22M | $23M | $23M | $23M | · | $25M | $29M | $32M | · | $38M | |
| Other Non-current Liabilities | $862.0K | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $13M | · | $13M | $13M | $13M | · | $14M | |
| Total Liabilities | $567M | $518M | $523M | $536M | $540M | $713M | $736M | $733M | $727M | $717M | · | $731M | $739M | $735M | · | $743M | |
| Long-term Debt | · | · | $342M | · | · | · | $541M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $374M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-449M | $-451M | $-434M | $-424M | $-397M | $-352M | $-326M | $-310M | $-293M | $-274M | · | $-233M | $-214M | $-190M | · | $-136M | |
| Treasury Stock | $25M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $4.0K | $4.0K | $71.0K | $29.0K | $-56.0K | $-206.0K | $-643.0K | $-1M | $-1M | · | $-2M | $-3M | $-3M | · | $-5M | |
| Stockholders' Equity | $786M | $829M | $837M | $838M | $854M | $888M | $902M | $908M | $916M | $923M | $942M | $947M | $956M | $974M | $998M | $1.01B | |
| Liabilities + Equity | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Shares Outstanding | 127,917,946 | 129,653,642 | 128,145,333 | 128,885,101 | 128,681,713 | 128,356,327 | 128,145,333 | 128,061,944 | 127,851,113 | 127,434,786 | 127,369,142 | 127,261,476 | 127,144,418 | 127,200,491 | 126,913,992 | 126,562,037 |
Cash Flow 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $10M | $8M | $10M | $12M | $11M | $8M | $0 | $9M | $8M | $7M | $0 | $6M | $5M | $5M | $4M | |
| Amort. of Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | $8M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $1M | $2M | $3M | $5M | · | $0 | |
| Operating Cash Flow | $20M | $-8M | $1M | $9M | $20M | $-25M | $10M | $9M | $14M | $-26M | $18M | $-5M | $-2M | $-13M | $-4M | $-16M | |
| CapEx | $8M | $5M | $8M | $8M | $6M | $4M | $12M | $11M | $13M | $6M | $7M | $4M | $7M | $10M | $5M | $8M | |
| Investing Cash Flow | $-8M | $-5M | $-6M | $-277.0K | $-9M | $4M | $-5M | $-4M | $7M | $15M | $17M | $21M | $15M | $24M | $-1M | $-4M | |
| Stock Issued | $2M | $-338.0K | $431.0K | $765.0K | $-1M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $93.0K | $1M | $2M | $3M | |
| Net Stock Activity | · | $-338.0K | · | · | · | $949.0K | · | · | · | $816.0K | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-12M | $-338.0K | $431.0K | $765.0K | $-202M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $64.0K | $1M | $2M | $3M | |
| Net Change in Cash | · | · | · | $9M | · | · | · | $7M | $23M | $-11M | · | $17M | $13M | $12M | · | $-18M | |
| Taxes Paid | $711.0K | $0 | $57.0K | $0 | $458.0K | $0 | $-112.0K | $143.0K | $87.0K | $89.0K | $0 | $0 | $175.0K | $0 | $25.0K | $26.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-30M | · | · | · | $-32M | · | · | · | $-23M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-33M | · | · | · | · | · | · |
Profitability 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.6% | 43.3% | · | 42.8% | 42.6% | 43.6% | · | 44.6% | 44.1% | 41.9% | · | 41.0% | 40.8% | 40.0% | · | 38.0% | |
| Operating Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| Net Margin | 1.1% | -9.2% | · | -14.4% | -24.9% | -15.4% | · | -10.5% | -11.3% | -17.3% | · | -12.2% | -16.6% | -22.4% | · | -28.6% | |
| Pretax Margin | 0.91% | -9.4% | · | -14.1% | -25.3% | -15.3% | · | -10.6% | -11.6% | -17.7% | · | -14.1% | -18.1% | -24.6% | · | -30.8% | |
| EBITDA Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| ROA | 0.16% | -1.2% | · | -1.8% | -3.0% | -1.6% | · | -1.1% | -1.1% | -1.6% | · | -1.1% | -1.4% | -1.7% | · | -2.0% | |
| ROE | 0.27% | -2.0% | · | -3.1% | -5.1% | -2.9% | · | -1.9% | -2.0% | -2.9% | · | -1.9% | -2.4% | -3.0% | · | -3.4% | |
| ROIC | -1.0% | -2.1% | · | -3.3% | -5.5% | -3.2% | · | -2.3% | -2.4% | -3.2% | · | -2.2% | -2.9% | -3.3% | · | -3.6% |
Liquidity & Solvency 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.4 | · | 3.9 | 3.9 | 2.1 | · | 2.0 | 2.0 | 7.5 | · | 6.3 | 6.2 | 6.8 | · | 7.1 | |
| Quick Ratio | 3.0 | 3.7 | · | 3.3 | 3.1 | 1.8 | · | 1.7 | 1.7 | 6.2 | · | 4.7 | 4.4 | 4.6 | · | 4.4 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -18.1 | · | 8.5 | 11.8 | · | · | -284.2 |
Efficiency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 3.6 | 3.6 | · | 4.1 | 3.6 | 3.8 | · | 3.8 | 3.8 | 4.1 | · | 3.7 | 3.7 | 3.4 | · | 3.5 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 |
Valuation (TTM) 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $757M | $724M | · | $705M | $682M | $657M | · | $641M | $620M | $592M | · | $565M | $538M | $508M | · | $492M | |
| Net Income TTM | $-87M | $-115M | · | $-116M | $-107M | $-89M | · | $-82M | $-89M | $-101M | · | $-110M | $-127M | $-152M | · | $-142M | |
| Market Cap | $1.87B | $962M | · | $995M | $941M | $1.22B | · | $1.89B | $1.77B | $2.00B | · | $1.57B | $2.04B | $2.21B | · | $1.09B | |
| Enterprise Value | $2.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -60.8 | -30.9 | · | -32.2 | -30.5 | -39.5 | · | -61.5 | -57.8 | -65.5 | · | -51.2 | -67.0 | -72.5 | · | -35.9 | |
| P/S | 2.5 | 1.3 | · | 1.4 | 1.4 | 1.9 | · | 2.9 | 2.9 | 3.4 | · | 2.8 | 3.8 | 4.4 | · | 2.2 | |
| P/B | 2.4 | 1.2 | · | 1.2 | 1.1 | 1.4 | · | 2.1 | 1.9 | 2.2 | · | 1.7 | 2.1 | 2.3 | · | 1.1 | |
| P / Tangible Book | · | 37.2 | · | 50.3 | 33.5 | 35.6 | · | 50.5 | 48.3 | 55.8 | · | 36.6 | 47.8 | 42.4 | · | 14.9 | |
| P / Cash Flow | · | -118.2 | · | · | · | -48.1 | · | · | · | -77.3 | · | · | · | -174.5 | · | · | |
| P / FCF | · | -73.2 | · | · | · | -40.8 | · | · | · | -63.6 | · | · | · | -97.9 | · | · | |
| EV / EBITDA | -214.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 2.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.6% | -3.2% | · | -3.1% | -3.3% | -2.5% | · | -1.6% | -1.7% | -1.5% | · | -1.9% | -1.5% | -1.4% | · | -2.8% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $727M | $661M | $592M | $510M | $484M |
| Gross Margin % | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% |
| Operating Margin % | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% |
| Net Income | $-108M | $-79M | $-88M | $-144M | $-8M |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debt / Equity | 0.4 | 0.6 | — | — | — |
| Current Ratio | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-22M | $-34M | $-31M | $-97M | $-91M |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 299 filers · $1.8B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 64 (+22 vs prior Q) | 38 (+1 vs prior Q) | 93 (+20 vs prior Q) | 59 (-26 vs prior Q) | +33.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| First Light Asset Management, LLC | $179,158,241 | 12,279,523 | 9.76% | Shares |
| VANGUARD GROUP INC | $150,953,759 | 12,836,204 | 8.22% | Shares |
| FIRST TRUST ADVISORS LP | $147,552,477 | 10,113,261 | 8.04% | Shares |
| Greenhouse Funds LLLP | $125,097,724 | 8,574,210 | 6.82% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117,615,272 | 8,061,362 | 6.41% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $84,082,418 | 5,763,017 | 4.58% | Shares |
| STATE STREET CORP | $78,257,609 | 5,363,784 | 4.26% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $73,501,000 | 5,037,787 | 4.00% | Shares |
| BRAIDWELL LP | $71,756,567 | 4,918,202 | 3.91% | Shares |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $61,886,083 | 4,342,883 | 3.37% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $50,558,727 | 3,465,300 | 2.75% | Call option |
| MILLENNIUM MANAGEMENT LLC | $44,930,518 | 3,079,542 | 2.45% | Shares |
| TORONTO DOMINION BANK | $43,770,000 | 3,000,000 | 2.38% | Call option |
| GEODE CAPITAL MANAGEMENT, LLC | $42,933,596 | 2,942,009 | 2.34% | Shares |
| Driehaus Capital Management LLC | $36,604,049 | 2,508,845 | 1.99% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $34,896,129 | 2,391,784 | 1.90% | Shares |
| AMERICAN CAPITAL MANAGEMENT INC | $32,648,145 | 2,237,707 | 1.78% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $32,593,724 | 2,233,977 | 1.78% | Shares |
| UBS Group AG | $32,581,659 | 2,233,150 | 1.78% | Call option |
| LOOMIS SAYLES & CO L P | $30,838,504 | 2,113,674 | 1.68% | Shares |
| Aberdeen Group plc | $28,180,950 | 1,931,525 | 1.54% | Shares |
| D. E. Shaw & Co., Inc. | $27,938,858 | 1,914,932 | 1.52% | Shares |
| GLENMEDE TRUST CO NA | $20,985,657 | 1,438,359 | 1.14% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17,689,018 | 1,212,407 | 0.96% | Shares |
| SEGALL BRYANT & HAMILL, LLC | $15,850,518 | 1,086,396 | 0.86% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $12,685,640 | 869,475 | 0.69% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $11,918,848 | 816,919 | 0.65% | Shares |
| SAMLYN CAPITAL, LLC | $11,869,359 | 813,527 | 0.65% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $11,707,337 | 802,422 | 0.64% | Shares |
| Glenmede Investment Management, LP | $11,359,995 | 1,471,502 | 0.62% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $9,141,555 | 626,563 | 0.50% | Shares |
| HighMark Wealth Management LLC | $8,936,871 | 612,534 | 0.49% | Shares |
| JUPITER ASSET MANAGEMENT LTD | $7,841,935 | 537,487 | 0.43% | Shares |
| Public Sector Pension Investment Board | $6,526,545 | 447,330 | 0.36% | Shares |
| Trexquant Investment LP | $6,358,074 | 435,783 | 0.35% | Shares |
| GOLDMAN SACHS GROUP INC | $5,559,884 | 381,075 | 0.30% | Shares |
| Bank of New York Mellon Corp | $5,554,938 | 380,736 | 0.30% | Shares |
| Granite Investment Partners, LLC | $5,181,507 | 355,141 | 0.28% | Shares |
| RHUMBLINE ADVISERS | $4,624,054 | 316,935 | 0.25% | Shares |
| AMERIPRISE FINANCIAL INC | $4,623,822 | 316,917 | 0.25% | Shares |
| Weiss Asset Management LP | $4,171,558 | 285,919 | 0.23% | Shares |
| Swiss National Bank | $3,800,695 | 260,500 | 0.21% | Shares |
| SUSQUEHANNA ADVISORS GROUP, INC. | $3,770,056 | 258,400 | 0.21% | Shares |
| STATE OF WISCONSIN INVESTMENT BOARD | $3,680,109 | 252,235 | 0.20% | Shares |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3,455,481 | 236,839 | 0.19% | Shares |
| FMR LLC | $3,409,026 | 233,655 | 0.19% | Shares |
| Squarepoint Ops LLC | $3,239,505 | 222,036 | 0.18% | Shares |
| ExodusPoint Capital Management, LP | $3,128,811 | 214,449 | 0.17% | Shares |
| Legal & General Group Plc | $2,907,700 | 199,294 | 0.16% | Shares |
| PEAK6 LLC | $2,651,003 | 181,700 | 0.14% | Call option |
| FEDERATED HERMES, INC. | $2,510,064 | 172,040 | 0.14% | Shares |
| BANK OF AMERICA CORP /DE/ | $2,221,357 | 152,252 | 0.12% | Shares |
| WHITE PINE CAPITAL LLC | $2,167,184 | 148,539 | 0.12% | Shares |
| PRUDENTIAL FINANCIAL INC | $2,017,870 | 138,305 | 0.11% | Shares |
| AMERICAN CENTURY COMPANIES INC | $1,987,158 | 136,200 | 0.11% | Shares |
| BlackRock, Inc. | $1,962,691 | 134,523 | 0.11% | Shares |
| WELLS FARGO & COMPANY/MN | $1,943,067 | 133,178 | 0.11% | Shares |
| STEELHEAD PARTNERS LLC | $1,885,028 | 129,200 | 0.10% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $1,787,859 | 122,540 | 0.10% | Shares |
| Greenhouse Funds LLLP | $1,689,522 | 115,800 | 0.09% | Call option |
| PERKINS CAPITAL MANAGEMENT INC | $1,605,483 | 110,040 | 0.09% | Shares |
| GABELLI FUNDS LLC | $1,597,605 | 109,500 | 0.09% | Shares |
| ARISTEIA CAPITAL, L.L.C. | $1,571,343 | 107,700 | 0.09% | Shares |
| IEQ CAPITAL, LLC | $1,524,305 | 104,476 | 0.08% | Shares |
| Verition Fund Management LLC | $1,477,019 | 101,235 | 0.08% | Shares |
| GAMCO INVESTORS, INC. ET AL | $1,459,000 | 100,000 | 0.08% | Shares |
| Fernwood Investment Management, LLC | $1,453,536 | 88,200 | 0.08% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1,440,244 | 194,103 | 0.08% | Shares |
| XTX Topco Ltd | $1,413,552 | 96,885 | 0.08% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $1,403,354 | 96,186 | 0.08% | Shares |
| CITADEL ADVISORS LLC | $1,324,772 | 90,800 | 0.07% | Call option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,279,178 | 87,675 | 0.07% | Shares |
| Curi Capital, LLC | $1,256,666 | 86,132 | 0.07% | Shares |
| MFG WEALTH MANAGEMENT, INC. | $1,217,711 | 83,462 | 0.07% | Shares |
| ALLIANCEBERNSTEIN L.P. | $1,189,723 | 160,340 | 0.06% | Shares |
| MetLife Investment Management, LLC | $1,120,293 | 76,785 | 0.06% | Shares |
| Mariner, LLC | $1,117,405 | 76,587 | 0.06% | Shares |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1,039,421 | 71,242 | 0.06% | Shares |
| TWO SIGMA ADVISERS, LP | $983,136 | 83,600 | 0.05% | Shares |
| Russell Investments Group, Ltd. | $967,068 | 66,283 | 0.05% | Shares |
| VOYA INVESTMENT MANAGEMENT LLC | $962,429 | 65,965 | 0.05% | Shares |
| MORGAN STANLEY | $954,638 | 65,431 | 0.05% | Shares |
| Quantinno Capital Management LP | $945,359 | 64,795 | 0.05% | Shares |
| Illinois Municipal Retirement Fund | $932,520 | 63,915 | 0.05% | Shares |
| WINTON GROUP Ltd | $924,700 | 63,379 | 0.05% | Shares |
| Quantbot Technologies LP | $922,540 | 63,231 | 0.05% | Shares |
| CHOREO, LLC | $889,115 | 60,940 | 0.05% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $884,373 | 60,615 | 0.05% | Shares |
| MOODY NATIONAL BANK TRUST DIVISION | $860,445 | 58,975 | 0.05% | Shares |
| Louisiana State Employees Retirement System | $833,089 | 57,100 | 0.05% | Shares |
| SIMPLEX TRADING, LLC | $796,453 | 54,589 | 0.04% | Shares |
| JANE STREET GROUP, LLC | $786,401 | 53,900 | 0.04% | Call option |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $786,109 | 53,880 | 0.04% | Shares |
| Teton Advisors, LLC | $774,729 | 53,100 | 0.04% | Shares |
| Invesco Ltd. | $766,515 | 52,537 | 0.04% | Shares |
| COMMERCE BANK | $764,632 | 52,408 | 0.04% | Shares |
| Vanguard Global Advisers, LLC | $741,070 | 50,793 | 0.04% | Shares |
| BARD ASSOCIATES INC | $683,761 | 46,865 | 0.04% | Shares |
| Alamea Verwaltungs GmbH | $683,702 | 46,861 | 0.04% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $674,467 | 46,228 | 0.04% | Shares |
Company insiders 52 insiders · 30 officers · 23 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Anthony P. Zook | Chief Executive Officer | June 1, 2025 M | 20,166 | 0 | 0 | $0 |
| Christopher M Smith | Chief Executive Officer | Feb. 23, 2025 M | 641,585 | 0 | 0 | $0 |
| Mark Mallon | Chief Executive Officer | March 1, 2022 A | 368,051 | 0 | 0 | $0 |
| Jeffrey Scott Sherman | Chief Financial Officer | May 11, 2025 M | 168,332 | 0 | 0 | $0 |
| William Bonello | Chief Financial Officer | April 28, 2022 M | 191,548 | 0 | 0 | $0 |
| Sharon Virag | Chief Financial Officer | March 1, 2019 A | 10,944 | 0 | 0 | $0 |
| Vishal Sikri | President Advanced Diagnostics | Feb. 23, 2024 A | 148,455 | 0 | 0 | $0 |
| David Sholehvar | President, Clinical Services | Aug. 1, 2022 A | 43,216 | 0 | 0 | $0 |
| George Cardoza | President & COO, Lab Ops | March 2, 2022 F | 244,157 | 0 | 0 | $0 |
| Gina M Wallar | President, Pharma Services | March 1, 2022 A | 33,443 | 0 | 0 | $0 |
| Clive Morris | President of Inivata | Dec. 30, 2021 A | 41,280 | 0 | 0 | $0 |
| Robert J. Shovlin | President, Clinical Services | May 25, 2021 M | 150,101 | 0 | 0 | $0 |
| Warren Stone | Pres & Chief Operating Officer | May 11, 2025 M | 108,280 | 0 | 0 | $0 |
| Alicia C Olivo | EVP, GC & Business Development | Sept. 1, 2025 F | 47,940 | 0 | 0 | $0 |
| Melody Harris | Chf Ops Off, Pres, Informatics | Feb. 23, 2025 M | 109,755 | 0 | 0 | $0 |
| Shashikant Kulkarni | Chief Scientific Officer | April 1, 2023 F | 82,673 | 0 | 0 | $0 |
| Cynthia J Dieter | Chief Accounting Officer | March 2, 2023 F | 29,765 | 0 | 0 | $0 |
| Douglas Matthew Brown | Chief Strategy Officer | April 1, 2022 A | 158,684 | 0 | 0 | $0 |
| Halley E Gilbert | Chief Legal Officer | March 1, 2022 A | 147,396 | 0 | 0 | $0 |
| Kathryn B Mckenzie | Chief Sustainability/Risk Ofcr | Jan. 11, 2022 M | 49,361 | 0 | 0 | $0 |
| Jennifer Balliet | VP and Chief Culture Officer | Dec. 30, 2021 A | 48,615 | 0 | 0 | $0 |
| Lawrence Martin Weiss | Chief Medical Officer | April 22, 2021 M | 130,847 | 0 | 0 | $0 |
| Denise E Pedulla | General Counsel | March 2, 2021 A | 60,643 | 0 | 0 | $0 |
| Steven G. Brodie | VP - Pharma Operations | Oct. 22, 2018 M | 45,953 | 0 | 0 | $0 |
| Steven A Ross | CIO | May 10, 2018 X | 4,500 | 0 | 0 | $0 |
| Maher Albitar | Chief Medical Officer | May 25, 2017 A | 60,692 | 0 | 0 | $0 |
| Mark Alan Machulcz | Vice President of Operations | Jan. 28, 2016 A | — | 0 | 0 | $0 |
| Robert H. Horel | Vice President GM PathLogic | Dec. 29, 2015 X | 51,218 | 0 | 0 | $0 |
| Robert P Gasparini | Chief Science Officer | May 22, 2014 X | 8,439 | 0 | 0 | $0 |
| Mark W Smits | Chief Commercial Officer | May 18, 2011 M | 0 | 0 | 0 | $0 |
| Carolyn S Starrett | Director | June 23, 2026 A | — | 0 | 0 | $0 |
| Lynn A. Tetrault | Director | June 15, 2026 S | 86,115 | 0 | 2 | $-118,824 |
| Marjorie C Green | Director | June 1, 2026 A | 22,964 | 0 | 0 | $0 |
| Neil Gunn | Director | June 1, 2026 A | 51,177 | 0 | 0 | $0 |
| Michael Aaron Kelly | Director | June 1, 2026 A | 67,086 | 0 | 0 | $0 |
| David Brian Perez | Director | June 1, 2026 A | 56,967 | 0 | 0 | $0 |
| John P. Kenny | Director | June 1, 2026 A | 5,893 | 0 | 0 | $0 |
| Stephen M Kanovsky | Director | June 1, 2026 A | 75,421 | 0 | 0 | $0 |
| Felicia Williams | Director | June 1, 2026 A | 30,237 | 0 | 0 | $0 |
| Elizabeth Floegel | Director | June 1, 2025 A | 23,590 | 0 | 0 | $0 |
| Alison L. Hannah | Director | June 1, 2025 M | 131,023 | 0 | 0 | $0 |
| Bruce K Crowther | Director | Aug. 10, 2023 A | 65,120 | 0 | 0 | $0 |
| Rachel A Stahler | Director | June 10, 2022 A | 21,335 | 0 | 0 | $0 |
| David Daly | Director | June 10, 2022 A | 17,179 | 0 | 0 | $0 |
| Kevin C Johnson | Director | Dec. 22, 2021 M | 37,398 | 0 | 0 | $0 |
| Douglas M Van Oort | Director | Aug. 1, 2021 F | 2,468,797 | 0 | 0 | $0 |
| Steven C Jones | Director | Jan. 7, 2021 M | 90,218 | 0 | 0 | $0 |
| Raymond R Hipp | Director | Nov. 16, 2020 S | 66,800 | 0 | 0 | $0 |
| William J Robison | Director | May 25, 2017 A | 183,348 | 0 | 0 | $0 |
| Michael T Dent | Director | Dec. 4, 2014 S | 1,384,150 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| IRS IDENTIFICATION NO. NeoGenomics, Inc. | April 12, 2007 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 62 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1.12% | 167,212 SH | Aug. 8, 2026 | Daily |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1.09% | 113,008 SH | Aug. 8, 2026 | Daily |
| LFSC · RBB Fund, Inc. | 0.43% | 43,071 NS | May 31, 2026 | N-PORT |
| IHF · iShares Trust | 0.31% | 243,554 SH | Aug. 8, 2026 | Daily |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.14% | 154,408 NS | April 30, 2026 | N-PORT |
| IJT · iShares Trust | 0.13% | 700,692 SH | Aug. 8, 2026 | Daily |
| XJR · iShares Trust | 0.13% | 15,435 SH | Aug. 8, 2026 | Daily |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.12% | 19,262 SH | Aug. 8, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.12% | 211,878 SH | Aug. 8, 2026 | Daily |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.12% | 89,895 SH | Aug. 8, 2026 | Daily |
| IWN · iShares Trust | 0.12% | 1,117,630 SH | Aug. 8, 2026 | Daily |
| IJR · iShares Trust | 0.11% | 7,947,524 SH | Aug. 8, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.11% | 104,297 SH | Aug. 8, 2026 | Daily |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.10% | 455,144 SH | Aug. 8, 2026 | Daily |
| NUSC · Nushares ETF Trust | 0.10% | 135,666 NS | April 30, 2026 | N-PORT |
| IJS · iShares Trust | 0.09% | 489,210 SH | Aug. 8, 2026 | Daily |
| VIOV · VANGUARD ADMIRAL FUNDS | 0.09% | 116,046 SH | Aug. 8, 2026 | Daily |
| ESML · iShares Trust | 0.09% | 158,897 SH | Aug. 8, 2026 | Daily |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.07% | 93,313 NS | April 30, 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0.07% | 13,856 NS | May 31, 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.07% | 85,056 SH | Aug. 8, 2026 | Daily |
| IWM · iShares Trust | 0.06% | 3,340,583 SH | Aug. 8, 2026 | Daily |
| ISCG · iShares Trust | 0.06% | 40,428 SH | Aug. 8, 2026 | Daily |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.06% | 49,165 NS | April 30, 2026 | N-PORT |
| SAA · ProShares Trust | 0.06% | 1,546 NS | May 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.06% | 757,699 SH | Aug. 8, 2026 | Daily |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.05% | 33,295 NS | April 30, 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.05% | 1,728,845 SH | Aug. 8, 2026 | Daily |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.04% | 106,278 NS | May 31, 2026 | N-PORT |
| RSSL · Global X Funds | 0.04% | 55,874 NS | April 30, 2026 | N-PORT |
| ITWO · ProShares Trust | 0.03% | 6,071 NS | May 31, 2026 | N-PORT |
| ISCB · iShares Trust | 0.03% | 5,811 SH | Aug. 8, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.03% | 388,986 SH | Aug. 8, 2026 | Daily |
| SCHA · SCHWAB STRATEGIC TRUST | 0.03% | 628,556 NS | May 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.03% | 425,333 NS | April 30, 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.03% | 14,399 NS | April 30, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 1,492,431 SH | Aug. 8, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.02% | 2,990,594 SH | Aug. 8, 2026 | Daily |
| UWM · ProShares Trust | 0.02% | 4,748 NS | May 31, 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 60,531 NS | April 30, 2026 | N-PORT |
| WSML · iShares Trust | 0.02% | 7,690 SH | Aug. 8, 2026 | Daily |
| SMLF · iShares Trust | 0.02% | 45,201 SH | Aug. 8, 2026 | Daily |
| URTY · ProShares Trust | 0.01% | 4,804 NS | May 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 5,288 NS | April 30, 2026 | N-PORT |
| IWO · iShares Trust | 0.01% | 113,167 SH | Aug. 8, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 12,627 SH | Aug. 8, 2026 | Daily |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 5,219 NS | May 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 339,840 NS | April 30, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.01% | 15,340 NS | April 30, 2026 | N-PORT |
| HDG · ProShares Trust | 0.01% | 121 NS | May 31, 2026 | N-PORT |